As people acclimatize to the new normal, it's time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections.
The problem? Novavax arrived late to the market.
At least one Wall Street analyst expects the COVID-19 vaccine producer to underperform.
Novavax (NVAX) sinks to a new record level 52-week low after analysts at JP Morgan cut the 12-month target price on the stock by more than $100.
Moderna Inc. (NASDAQ: MRNA) and Novavax Inc. (NASDAQ: NVAX) were trading down over 2% and 4%, respectively in the premarket Friday despite both stocks showing signs a bounce could be in the cards.
This segment originally aired on September 22, 2022. Yahoo Finance Live's Julie Hyman discusses Novavax stock performance after JPMorgan downgrades its shares to Underweight from Neutral.

Why Novavax Stock Is Plunging This Week

04:43pm, Thursday, 22'nd Sep 2022
Novavax has some serious short-term challenges but could still have growth opportunities in the future.
Novavax stock is trading at a two-year low amid slowly ramping use of its Covid vaccine, dubbed Nuvaxovid, in the U.S. The post Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak appear

Why Is Novavax (NVAX) Stock Falling Today?

09:44am, Thursday, 22'nd Sep 2022
Novavax (NASDAQ: NVAX ) stock fell 6% on Sept. 21, and kept falling overnight, after a JP Morgan Chase analyst cut his price target from over $100/share down to just $27 with an “underperform” ra

Novavax Stock Slammed With Hefty Price-Target Cut

09:42am, Thursday, 22'nd Sep 2022
The shares of Novavax, Inc. (NASDAQ:NVAX) are 4.9% lower this morning, last seen trading at $24.60, following a bear note from J.P.
NVAX is a risk-on stock at a time investors are turning to risk-off assets. This article looks to see if Novavax still presents an opportunity for investors
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Vaccine Stocks: Down but Not Out?

06:29pm, Monday, 19'th Sep 2022
Whether the pandemic is over or not, plenty of people are still looking for protection against COVID-19.
The latest pronouncements by the president aren't exactly doing the two healthcare companies any favors.
It's a mixed day for the stock market, but it's not a good day for vaccine stocks. Across the board, these names are getting sold.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE